Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes

Detalles Bibliográficos
Autor principal: Son, Jang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937850/
https://www.ncbi.nlm.nih.gov/pubmed/33677927
http://dx.doi.org/10.3803/EnM.2021.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937850/
https://www.ncbi.nlm.nih.gov/pubmed/33677927
http://dx.doi.org/10.3803/EnM.2021.109

Ejemplares similares